CELLINK Bioprinting AB (CELLINK) has announced a change of leadership with Stefan Blomsterberg taking over as CEO from Cecilia Edebo who will be pursuing another opportunity. Stefan Blomsterberg has been appointed as the new CEO of CELLINK. Cecilia Edebo, current CEO, requested earlier this year to resign from her position to pursue a new career […] The post Stefan Blomsterberg appointed as new CEO of CELLINK Bioprinting AB appeared first on CELLINK.| CELLINK
CELLINK and Ossiform look to capitalize on synergies and bring to the market a highly functional bioink for bone-based research. The partnership has scope for additional materials, including clinical grade bioinks. (November 30, Gothenburg – Odense): CELLINK and Ossiform have entered a strategic partnership to join forces to commercialize a ready-to-print bioink based on Ossiform’s […] The post CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink bas...| CELLINK
Gothenburg, October 18th 2023 — CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine and tissue engineering with the launch of CELLINK Vivoink, the first-ever medical-grade bioink specially designed to support researchers on their clinical translational journey. CELLINK Vivoink is optimized for superior printability, […] The post CELLINK Announces CELLINK Vivoink: Our First Medical-Grade Bioink appeared ...| CELLINK
San Diego, USA, October 10th, 2023 – CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge […] The post CELLINK and the University of California, San Diego Partner to Open a 3D Bioprin...| CELLINK
Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models. (October 4th 2023, Gothenburg, Sweden) Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for […] The post Carcinotech and CELLINK Enter a Partnership to Develop and Comm...| CELLINK
CELLINK, a global leader in 3D bioprinting technologies, is excited to announce a strategic distribution agreement with Paralab, marking a significant expansion of its presence in Portugal and Spain. This collaboration brings CELLINK’s state-of-the-art bioprinting solutions to a broader audience in Southern Europe, reinforcing the company’s commitment to advancing regenerative medicine while respecting regional nuances. […] The post CELLINK Expands Bioprinting Reach in Portugal and Spai...| CELLINK
CELLINK, a global leader in 3D bioprinting technologies, is pleased to announce the signing of a distribution agreement with AXT, a prominent player within the scientific equipment landscape in Australia and the wider Oceania region. This strategic collaboration bolsters CELLINK’s growing presence in the region and represents another milestone in their ongoing expansion efforts. (July […] The post CELLINK and AXT Join Forces to Expand Access to Innovative Bioprinting Technologies in Ocean...| CELLINK
Gothenburg, Sweden – CELLINK, a global leader in bioprinting, today announced the release of the third generation of their LUMEN X™ product – the new standard for benchtop DLP bioprinting. This cutting-edge product boasts a significant improvement in printer resolution, and developments in advanced features including the ability to develop multi-stiffness constructs, microfluidic systems, and a […] The post CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprin...| CELLINK
The European-funded PRISM-LT project is set to shape the future of engineered living materials in the European Union. The project aims to develop a versatile bioprinting platform that addresses critical challenges in the adoption of these technologies and primarily targets biomedical and food applications. Recent advancements in cell engineering and additive manufacturing have created exciting […] The post PRISM-LT: A New European-Funded Project to Revolutionize Bioprinting of Living Materi...| CELLINK
CELLINK and Nanyang Technological University launch joint lab to explore bioprinting in regenerative medicine and drug discovery.| CELLINK
CELLINK leads the way in 3D bioprinting innovation, developing bioprinters and bioinks for pharma, academic and industry researchers.| CELLINK
Explaining 3D bioprinting, what it is, and the process from ideation to the printed construct and the post-print process.| CELLINK